Chapter 03
Longevity is the modality patients age into. The Protocol MD framework treats it as a layered, multi-pathway intervention — not a single ‘anti-aging’ injection.

62%
of patients over 40 report measurable improvements in sleep and morning energy in cycle one
3
complementary pathways targeted in every longevity protocol — cellular, mitochondrial, hormonal
12 wk
minimum cycle length our physicians recommend to evaluate longevity outcomes
The Clinical Picture
Longevity protocols combine Epitalon, NAD+, MOTS-c, and Thymosin Alpha-1 to address cellular signaling, mitochondrial function, and immune resilience together.
There is no single ‘longevity peptide.’ Your physician selects from this stack based on lab markers, family history, and goals.
What To Expect
Week 1–4
Sleep and morning energy shift first. Most patients describe ‘a quieter system.’
Week 5–10
Resting HRV trends up. Recovery from training and travel feels smoother.
Week 11–12
Re-test labs. Physician adjusts dose or rotates the stack for the next cycle.
FAQ